Your Location：
Home >
Browse articles >
Advances in management of acute promyelocytic leukemia with arsenic trioxide
Updated：2021-08-27
|

    • Advances in management of acute promyelocytic leukemia with arsenic trioxide

    • Chinese Journal of Integrative Medicine   Vol. 13, Issue 2, Pages: 92-94(2007)

    • DOI：10.1007/s11655-007-0092-y    

      CLC：

    • Published：2007，

    Scan for full text

  • Ma Jun. Advances in management of acute promyelocytic leukemia with arsenic trioxide. [J]. Chinese Journal of Integrative Medicine 13(2):92-94(2007) DOI： 10.1007/s11655-007-0092-y.

  •  
  •  
FULL TEXT LINK
More>

0

Views

367

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Integrative oncology meets immunotherapy: New prospects for combination therapy grounded in Eastern medical knowledge
Synergism between carnosic acid and arsenic trioxide on induction of acute myeloid leukemia cell apoptosis is associated with modulation of PTEN/Akt signaling pathway
Effect and prognostic analysis of treatment for acute myeloid leukemia using Chinese drugs combined with chemotherapy
Tanshinone IIA: a potent, natural anti-carcinogenic agent for the management of systemic malignancies
Effects of langchuangjing granule on apoptotic of CD4 + T and CD19 + B in spleen of BXSB mice with systemic lupus erythematosus

Related Author

No data

Related Institution

Department of Epidemiology, Mailman School of Public Health, Columbia University
Nuffield Department of Medicine and Department of Primary Health Care, University of Oxford
Global Initiative for Traditional Systems (GIFTS) of Health
Department of Health Care, Qilu Hospital of Shandong University
Department of Scientific Research, Qilu Hospital of Shandong University
0